关注
Federica Bello
Federica Bello
在 unifi.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ...
Arthritis & rheumatology 74 (2), 295-306, 2022
1202022
Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology
F Fagni, F Bello, G Emmi
Frontiers in Medicine 8, 627776, 2021
852021
Type I interferon–related kidney disorders
L Lodi, MV Mastrolia, F Bello, GM Rossi, ML Angelotti, YJ Crow, ...
Kidney international 101 (6), 1142-1159, 2022
432022
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
A Bettiol, RA Sinico, F Schiavon, S Monti, EP Bozzolo, F Franceschini, ...
European Respiratory Journal 57 (5), 2021
232021
GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton
C Wolf, A Pouya, S Bitar, A Pfeiffer, D Bueno, L Rojas-Charry, S Arndt, ...
Communications Biology 5 (1), 541, 2022
192022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study
A Bettiol, ML Urban, F Bello, D Fiori, I Mattioli, G Lopalco, F Iannone, ...
Annals of the Rheumatic Diseases, 2022
172022
Biologics for eosinophilic granulomatosis with polyangiitis
M Caminati, M Maule, F Bello, G Emmi
Current opinion in allergy and clinical immunology 23 (1), 36-43, 2023
152023
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
M Caminati, A Fassio, F Alberici, C Baldini, F Bello, P Cameli, E Conticini, ...
Allergy 79 (2), 516-519, 2024
112024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study
A Bettiol, ML Urban, R Padoan, M Groh, G Lopalco, A Egan, V Cottin, ...
The Lancet Rheumatology 5 (12), e707-e715, 2023
102023
At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement
M Bond, F Fagni, M Moretti, F Bello, A Egan, A Vaglio, G Emmi, C Dejaco
Current Rheumatology Reports 24 (11), 337-351, 2022
92022
Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis
F Bello, A Marchi, D Prisco, I Olivotto, G Emmi
Rheumatology 59 (11), e88-e90, 2020
92020
Cluster analysis to explore clinical subphenotypes of eosinophilic granulomatosis with polyangiitis
E Rubenstein, C Maldini, A Vaglio, F Bello, JP Bremer, F Moosig, ...
The Journal of rheumatology 50 (11), 1446-1453, 2023
82023
Gut microbiota and associated mucosal immune response in eosinophilic granulomatosis with polyangiitis (EGPA)
E Niccolai, A Bettiol, S Baldi, E Silvestri, L Di Gloria, F Bello, G Nannini, ...
Biomedicines 10 (6), 1227, 2022
72022
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis
A Bettiol, FR Argento, E Fini, F Bello, G Di Scala, N Taddei, G Emmi, ...
Thrombosis research 230, 1-10, 2023
52023
Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response
F Bello, G Emmi, C Tamburini, L Maggi, F Annunziato, L Cosmi, D Prisco
Clinical and experimental rheumatology 40 (4), 863-864, 2022
52022
GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton. Commun Biol 5, 541 (2022)
C Wolf, A Pouya, S Bitar, A Pfeiffer, D Bueno, L Rojas-Charry, S Arndt, ...
52022
The uncertain meaning of ANCA positivity in IgG4-related disease
F Bello
Rheumatology 60 (8), 3492-3493, 2021
42021
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis
F Bello, A Bettiol, E Silvestri, I Mattioli, ML Urban, A Palermo, M Mazzetti, ...
Rheumatology 62 (2), 835-840, 2023
32023
Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis
F Bello, F Maritati, A Radice, RA Sinico, G Emmi, A Vaglio
Annals of the Rheumatic Diseases 80 (9), 1247-1248, 2021
32021
Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis
D Malandrino, F Bello, G Lopalco, L Cantarini, I Olivotto, G Emmi, D Prisco
Internal and Emergency Medicine 19 (2), 583-588, 2024
22024
系统目前无法执行此操作,请稍后再试。
文章 1–20